RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

Saved in:
Bibliographic Details
Published in:The Turkish journal of gastroenterology 2023-03, Vol.34 (3), p.310-310
Main Authors: Ergenç, İlkay, Kani, Haluk Tarık, Karabacak, Murat, Cömert Özer, Elif, Mehdiyev, Shahin, Jafarov, Fuad, Abacar, Kerem Yiğit, Kutluğ Ağaçkıran, Seda, Sevik, Gizem, Aslan, Rahmi, Alibaz Öner, Fatma, İnanç, Nevsun, Atagündüz, Mehmet Pamir, Seçkin, Dilek, Özen Alahdab, Yeşim, Ergun, Tülin, Direskeneli, Haner, Atuğ, Özlen
Format: Article
Language:English
Subjects:
Biological Therapy
Hepatitis B Antibodies
Hepatitis B Surface Antigens
Hepatitis B virus - physiology
Humans
Immunoglobulin G
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 310
container_issue 3
container_start_page 310
container_title The Turkish journal of gastroenterology
container_volume 34
creator Ergenç, İlkay
Kani, Haluk Tarık
Karabacak, Murat
Cömert Özer, Elif
Mehdiyev, Shahin
Jafarov, Fuad
Abacar, Kerem Yiğit
Kutluğ Ağaçkıran, Seda
Sevik, Gizem
Aslan, Rahmi
Alibaz Öner, Fatma
İnanç, Nevsun
Atagündüz, Mehmet Pamir
Seçkin, Dilek
Özen Alahdab, Yeşim
Ergun, Tülin
Direskeneli, Haner
Atuğ, Özlen
description
doi_str_mv 10.5152/tjg.2023.237002
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f1f3bdabb9e94f249ed1b45ebc83a5f7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f1f3bdabb9e94f249ed1b45ebc83a5f7</doaj_id><sourcerecordid>2787213864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2732-813da690ffe3f1853ccb206d5a6d4c2b7ebb8dc489a896bb221fe25fdd5d5db83</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhoMgfp-9SY5eWpPJZjfrrZVqC6JS1OuSj8maut3Uzbbgv3fxizkMPO_LMzCEnHM2llzCVb-qx8BAjEEUjMEeOQKeqZHMWXFIjlNaMSYUz-GAHIq85KUSxRF5X86u6TKkdxo9nU9f6RK17cNO9yG2NLQDS5OaPmA9kB1S3To6afswn1q6qO_oU0zhO3gacmz7NAgshl1oazoNsYl1sPT5DTu9-Twl-143Cc9-9wl5uZ0938xH9493i5vJ_chCIWCkuHA6L5n3KDxXUlhrgOVO6txlFkyBxihnM1VqVebGAHCPIL1zchijxAlZ_Hhd1Ktq04W17j6rqEP1DWJXV7rrg22w8twL47QxJZaZh6xEx00m0VgltPTF4Lr8cW26-LHF1FfrkCw2jW4xblMFhSqAC5VnQ_Xit7o1a3T_h_-eLb4AhGJ_ag</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2787213864</pqid></control><display><type>article</type><title>RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy</title><source>Open Access: PubMed Central</source><creator>Ergenç, İlkay ; Kani, Haluk Tarık ; Karabacak, Murat ; Cömert Özer, Elif ; Mehdiyev, Shahin ; Jafarov, Fuad ; Abacar, Kerem Yiğit ; Kutluğ Ağaçkıran, Seda ; Sevik, Gizem ; Aslan, Rahmi ; Alibaz Öner, Fatma ; İnanç, Nevsun ; Atagündüz, Mehmet Pamir ; Seçkin, Dilek ; Özen Alahdab, Yeşim ; Ergun, Tülin ; Direskeneli, Haner ; Atuğ, Özlen</creator><creatorcontrib>Ergenç, İlkay ; Kani, Haluk Tarık ; Karabacak, Murat ; Cömert Özer, Elif ; Mehdiyev, Shahin ; Jafarov, Fuad ; Abacar, Kerem Yiğit ; Kutluğ Ağaçkıran, Seda ; Sevik, Gizem ; Aslan, Rahmi ; Alibaz Öner, Fatma ; İnanç, Nevsun ; Atagündüz, Mehmet Pamir ; Seçkin, Dilek ; Özen Alahdab, Yeşim ; Ergun, Tülin ; Direskeneli, Haner ; Atuğ, Özlen</creatorcontrib><identifier>EISSN: 2148-5607</identifier><identifier>DOI: 10.5152/tjg.2023.237002</identifier><identifier>PMID: 36919837</identifier><language>eng</language><publisher>Turkey: AVES</publisher><subject>Biological Therapy ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B virus - physiology ; Humans ; Immunoglobulin G</subject><ispartof>The Turkish journal of gastroenterology, 2023-03, Vol.34 (3), p.310-310</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36919837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ergenç, İlkay</creatorcontrib><creatorcontrib>Kani, Haluk Tarık</creatorcontrib><creatorcontrib>Karabacak, Murat</creatorcontrib><creatorcontrib>Cömert Özer, Elif</creatorcontrib><creatorcontrib>Mehdiyev, Shahin</creatorcontrib><creatorcontrib>Jafarov, Fuad</creatorcontrib><creatorcontrib>Abacar, Kerem Yiğit</creatorcontrib><creatorcontrib>Kutluğ Ağaçkıran, Seda</creatorcontrib><creatorcontrib>Sevik, Gizem</creatorcontrib><creatorcontrib>Aslan, Rahmi</creatorcontrib><creatorcontrib>Alibaz Öner, Fatma</creatorcontrib><creatorcontrib>İnanç, Nevsun</creatorcontrib><creatorcontrib>Atagündüz, Mehmet Pamir</creatorcontrib><creatorcontrib>Seçkin, Dilek</creatorcontrib><creatorcontrib>Özen Alahdab, Yeşim</creatorcontrib><creatorcontrib>Ergun, Tülin</creatorcontrib><creatorcontrib>Direskeneli, Haner</creatorcontrib><creatorcontrib>Atuğ, Özlen</creatorcontrib><title>RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy</title><title>The Turkish journal of gastroenterology</title><addtitle>Turk J Gastroenterol</addtitle><subject>Biological Therapy</subject><subject>Hepatitis B Antibodies</subject><subject>Hepatitis B Surface Antigens</subject><subject>Hepatitis B virus - physiology</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><issn>2148-5607</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kE1LAzEQhoMgfp-9SY5eWpPJZjfrrZVqC6JS1OuSj8maut3Uzbbgv3fxizkMPO_LMzCEnHM2llzCVb-qx8BAjEEUjMEeOQKeqZHMWXFIjlNaMSYUz-GAHIq85KUSxRF5X86u6TKkdxo9nU9f6RK17cNO9yG2NLQDS5OaPmA9kB1S3To6afswn1q6qO_oU0zhO3gacmz7NAgshl1oazoNsYl1sPT5DTu9-Twl-143Cc9-9wl5uZ0938xH9493i5vJ_chCIWCkuHA6L5n3KDxXUlhrgOVO6txlFkyBxihnM1VqVebGAHCPIL1zchijxAlZ_Hhd1Ktq04W17j6rqEP1DWJXV7rrg22w8twL47QxJZaZh6xEx00m0VgltPTF4Lr8cW26-LHF1FfrkCw2jW4xblMFhSqAC5VnQ_Xit7o1a3T_h_-eLb4AhGJ_ag</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Ergenç, İlkay</creator><creator>Kani, Haluk Tarık</creator><creator>Karabacak, Murat</creator><creator>Cömert Özer, Elif</creator><creator>Mehdiyev, Shahin</creator><creator>Jafarov, Fuad</creator><creator>Abacar, Kerem Yiğit</creator><creator>Kutluğ Ağaçkıran, Seda</creator><creator>Sevik, Gizem</creator><creator>Aslan, Rahmi</creator><creator>Alibaz Öner, Fatma</creator><creator>İnanç, Nevsun</creator><creator>Atagündüz, Mehmet Pamir</creator><creator>Seçkin, Dilek</creator><creator>Özen Alahdab, Yeşim</creator><creator>Ergun, Tülin</creator><creator>Direskeneli, Haner</creator><creator>Atuğ, Özlen</creator><general>AVES</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20230301</creationdate><title>RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy</title><author>Ergenç, İlkay ; Kani, Haluk Tarık ; Karabacak, Murat ; Cömert Özer, Elif ; Mehdiyev, Shahin ; Jafarov, Fuad ; Abacar, Kerem Yiğit ; Kutluğ Ağaçkıran, Seda ; Sevik, Gizem ; Aslan, Rahmi ; Alibaz Öner, Fatma ; İnanç, Nevsun ; Atagündüz, Mehmet Pamir ; Seçkin, Dilek ; Özen Alahdab, Yeşim ; Ergun, Tülin ; Direskeneli, Haner ; Atuğ, Özlen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2732-813da690ffe3f1853ccb206d5a6d4c2b7ebb8dc489a896bb221fe25fdd5d5db83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biological Therapy</topic><topic>Hepatitis B Antibodies</topic><topic>Hepatitis B Surface Antigens</topic><topic>Hepatitis B virus - physiology</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ergenç, İlkay</creatorcontrib><creatorcontrib>Kani, Haluk Tarık</creatorcontrib><creatorcontrib>Karabacak, Murat</creatorcontrib><creatorcontrib>Cömert Özer, Elif</creatorcontrib><creatorcontrib>Mehdiyev, Shahin</creatorcontrib><creatorcontrib>Jafarov, Fuad</creatorcontrib><creatorcontrib>Abacar, Kerem Yiğit</creatorcontrib><creatorcontrib>Kutluğ Ağaçkıran, Seda</creatorcontrib><creatorcontrib>Sevik, Gizem</creatorcontrib><creatorcontrib>Aslan, Rahmi</creatorcontrib><creatorcontrib>Alibaz Öner, Fatma</creatorcontrib><creatorcontrib>İnanç, Nevsun</creatorcontrib><creatorcontrib>Atagündüz, Mehmet Pamir</creatorcontrib><creatorcontrib>Seçkin, Dilek</creatorcontrib><creatorcontrib>Özen Alahdab, Yeşim</creatorcontrib><creatorcontrib>Ergun, Tülin</creatorcontrib><creatorcontrib>Direskeneli, Haner</creatorcontrib><creatorcontrib>Atuğ, Özlen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>The Turkish journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ergenç, İlkay</au><au>Kani, Haluk Tarık</au><au>Karabacak, Murat</au><au>Cömert Özer, Elif</au><au>Mehdiyev, Shahin</au><au>Jafarov, Fuad</au><au>Abacar, Kerem Yiğit</au><au>Kutluğ Ağaçkıran, Seda</au><au>Sevik, Gizem</au><au>Aslan, Rahmi</au><au>Alibaz Öner, Fatma</au><au>İnanç, Nevsun</au><au>Atagündüz, Mehmet Pamir</au><au>Seçkin, Dilek</au><au>Özen Alahdab, Yeşim</au><au>Ergun, Tülin</au><au>Direskeneli, Haner</au><au>Atuğ, Özlen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy</atitle><jtitle>The Turkish journal of gastroenterology</jtitle><addtitle>Turk J Gastroenterol</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>34</volume><issue>3</issue><spage>310</spage><epage>310</epage><pages>310-310</pages><eissn>2148-5607</eissn><cop>Turkey</cop><pub>AVES</pub><pmid>36919837</pmid><doi>10.5152/tjg.2023.237002</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2148-5607
ispartof The Turkish journal of gastroenterology, 2023-03, Vol.34 (3), p.310-310
issn 2148-5607
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f1f3bdabb9e94f249ed1b45ebc83a5f7
source Open Access: PubMed Central
subjects Biological Therapy
Hepatitis B Antibodies
Hepatitis B Surface Antigens
Hepatitis B virus - physiology
Humans
Immunoglobulin G
title RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A50%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RE:%20Risk%20of%20HBV%20Reactivation%20in%20HBsAg%20Negative%20and%20AntiHBc%20IgG%20Positive%20Patients%20Receiving%20Biologic%20Therapy&rft.jtitle=The%20Turkish%20journal%20of%20gastroenterology&rft.au=Ergen%C3%A7,%20%C4%B0lkay&rft.date=2023-03-01&rft.volume=34&rft.issue=3&rft.spage=310&rft.epage=310&rft.pages=310-310&rft.eissn=2148-5607&rft_id=info:doi/10.5152/tjg.2023.237002&rft_dat=%3Cproquest_doaj_%3E2787213864%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2732-813da690ffe3f1853ccb206d5a6d4c2b7ebb8dc489a896bb221fe25fdd5d5db83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2787213864&rft_id=info:pmid/36919837&rfr_iscdi=true